Examiner Mohammed Qureshi
Grant ratio: 50.7% (44th percentile in Art Unit 2834 among examiners with at least 20 applications). Average office actions per grant: 1.22. Most common rejection type: §112.
Recently active
Last office action in data: October 2026
Examiner record
- Examiner ID
- 97267
- Primary art unit
- 2834
- Work group
- 2830
- Technology center
- 2800
- Applications
- 229
- Granted applications
- 116
- Examiner phone
- (571) 272-8310
Save this analysis
Download this examiner report.
Log in / Sign Up to exportPeer comparisons
| Group | Examiners | Average grant ratio | Average office actions / grant |
|---|---|---|---|
| Art Unit | 56 | 55.3% | 1.54 |
| Group | 358 | 65.8% | 1.58 |
| Tech Center | 2,435 | 61.3% | 1.69 |
| USPTO | 16,620 | 51.8% | 1.98 |
Office actions per application
| Office actions | Applications | Share of applications |
|---|---|---|
| No OA observed | 2 | 0.9% |
| 1 OA | 188 | 82.1% |
| 2 OAs | 35 | 15.3% |
| 3 OAs | 4 | 1.7% |
| 4 OAs | 0 | 0.0% |
| 5+ OAs | 0 | 0.0% |
Each application is counted once. “5+” includes all higher counts.
Grant history
Recent ratios may be lower while applications remain pending.
Yearly counts
| Year | Applications | Grants | Grant rate |
|---|---|---|---|
| 2022 | 6 | 4 | 66.7% |
| 2023 | 54 | 42 | 77.8% |
| 2024 | 48 | 41 | 85.4% |
| 2025 | 57 | 29 | 50.9% |
| 2026 | 64 | 0 | 0.0% |
Rejections by office-action stage
| Office-action stage | Actions observed | §101 | §102 | §103 | §112 |
|---|---|---|---|---|---|
| Action 1 | 227 | 0.0% | 0.9% | 8.4% | 28.2% |
| Action 2 | 39 | 0.0% | 5.1% | 17.9% | 15.4% |
| Action 3 | 4 | 0.0% | 0.0% | 25.0% | 25.0% |
Section 101 rejections
Last 3 years: 2023-10-23–2026-10-23. All years includes every dated office action in the data.
By year
0.0%
0.0%
2024: AI examples
0.0%
2025: August memo
0.0%
0.0%
Each bar is the percentage of office actions with a §101 rejection.
PTAB appeals
No PTAB decisions could be matched to this examiner.
Older and transferred applications may not have a reliable examiner match. Data through Oct. 30, 2026.